For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Oxytocin | Oxytocin 2.5 U i.v. Oxytocin: Oxytocin 2.5 U i.v. | 0 | None | 0 | 112 | 50 | 112 | View |
| Carbetocin | Carbetocin 100 µg i.v. Carbetocin: Carbetocin 100 µg i.v. | 0 | None | 0 | 103 | 55 | 103 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Feeling hot | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA (4.1) | View |
| Chest pain | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA (4.1) | View |
| dyspnoea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA (4.1) | View |
| palpitations | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA (4.1) | View |
| flushing | SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDRA (4.1) | View |
| headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA (4.1) | View |
| dry mouth | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA (4.1) | View |
| nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA (4.1) | View |